Surgery Partners Inc. is a healthcare services company focused on providing high-quality, cost-effective solutions for surgical and related ancillary care in support of the company's patients and physicians. The company was founded in 2004 and is based in Nashville, Tennessee.
SGRY Price Forecast Based on DCF Valuation
DCF Fair Value Target:
The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Surgery Partners Inc. To summarize, we found that Surgery Partners Inc ranked in the 70th percentile in terms of potential gain offered. More precisely, our analysis suggests the stock is undervalued by approximately 148% on a DCF basis. The most interesting components of our discounted cash flow analysis for Surgery Partners Inc ended up being:
Interest coverage, a measure of earnings relative to interest payments, is 0.22 -- which is good for besting just 24.78% of its peer stocks (US stocks in the Healthcare sector with positive cash flow).
31% of the company's capital comes from equity, which is greater than only 9.14% of stocks in our cash flow based forecasting set.
Surgery Partners Inc's effective tax rate, as measured by taxes paid relative to net income, is at 0 -- greater than only 0% of US stocks with positive free cash flow.
Terminal Growth Rate in Free Cash Flow
Return Relative to Current Share Price
Want more companies with a valuation profile/forecast similar to that of Surgery Partners Inc? See ESMC, ABBV, CSTL, LH, and ALXN.
BRENTWOOD, Tenn., Jan. 25, 2021 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (Nasdaq: SGRY) (“Surgery Partners”) today announced that it has commenced an underwritten public offering of 6,000,000 shares of its common stock. All of the shares to be sold in the offering are to be sold by Surgery Partners. In connection with the offering, Surgery Partners intends to grant the underwriters a 30-day option to purchase up to an additional 900,000 shares of its common stock. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. J.P. Morgan Securities LLC and Jefferies LLC are acting as lead bookrunning managers, and Barclays Capital Inc., KKR Capital Markets LLC...
In this article, we presented the 10 best mid-cap stocks to buy according to billionaire Brian Higgins. Click to skip ahead and see the 5 Best Mid-Cap Stocks To Buy Billionaire Brian Higgins. Billionaire Brian Higgins, 55, is the co-founder of investment management firm King Street Capital Management. The New York-based firm is managing $17 […]
For FY20, Surgery Partners (SGRY) provided revenue guidance of ~$1.86B and reaffirmed its previous FY20 adj. EBITDA guidance range of $250 to $260M.Consistent with previous management statements, the company projects that in 2021, it will re-establish the multi-year double-digit; adj. growth trajectory and profit levels originally targeted based on a...